SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Shinar D, Rodan GA. Relationships and interaction between bone and bone marrow. In: LongMW, WichaMS, editors. The hematopoietic microenvironment: the functional and structural basis of blood cell development. Baltimore: The Johns Hopkins University Press, 1992: 79109.
  • 2
    Moore KL. The developing human: clinically oriented embryology, 4th ed. Philadelphia: WB Saunders, 1988.
  • 3
    Parfitt AM. The physiologic and clinical significance of bone histomorphometric data. In: ReckerRR, editor. Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press, Inc., 1983: 143223.
  • 4
    Zerwekh JE, Ruml LA, Gottschalk F, et al. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998; 13: 15941601.
  • 5
    Zaman G, Pitsillides AA, Rawlinson SCF, et al. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res. 1999; 14: 11231131.
  • 6
    Sakamoto S, Sakamoto M. Bone collagenase, osteoblasts and cell-mediated bone resorption. In: PeckWA, editor. Bone and mineral research, vol. 4. New York: Elsevier, 1986: 49102.
  • 7
    Noda M, Denhardt DT. Osteopontin. In: BilezikianJP, RaiszLG, RodanGA, editors. Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002: 141150.
  • 8
    McKee MD, Nanci A. Osteopontin and the bone remodeling sequence: colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein. In: DempsterDT, ButlerWT, ChambersAF, SengerDR, editors. Osteopontin: role in cell signalling and adhesion, vol. 760. New York: The New York Academy of Sciences, 1995: 177200.
  • 9
    Yoshitaki H, Rittling SR, Denhardt DT, et al. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA. 1999; 96: 81568160.
  • 10
    Yumoto K, Ishijima M, Rittling R, et al. Osteopontin deficiency protects joints against destruction in anti-Type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA. 2002; 99: 45564561.
  • 11
    Takahashi N, Udagawa N, Takami M, et al. Cells of bone: osteoclast generation. In: BilezikianJP, RaiszLG, RodanGA, editors. Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002: 109126.
  • 12
    Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289: 15041508.
  • 13
    Michigami T, Kageyama T, Satomura K, et al. Novel mutations in the α3 subunit of vacuolar H+-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone. 2002; 30: 436439.
  • 14
    Vaananen K, Zhao H. Osteoclast function: biology and mechanisms. In: BilezikianJP, RaiszLG, RodanGA, editors. Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002: 127140.
  • 15
    Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000; 289: 15081514.
  • 16
    Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89: 309319.
  • 17
    Diel SJ. Bisphosphonates in the prevention of bone metastases: current evidence. Semin Oncol. 2001; 28 (Suppl 11): 7580.
  • 18
    Sato M, Grasser W, Endo N. et al. Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991; 88: 20952105.
  • 19
    Fleisch H, Reszka A, Rodan GA, et al. In: BilezikianJP, RaiszLG, RodanGA, editors. Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002: 13611385.
  • 20
    Aubin JE, Triffitt JT. Mesenchymal stem cells and osteoblast differentiation. In: BilezikianJP, RaiszLG, RodanGA, editors. Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002: 5981.
  • 21
    Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000; 289: 15011504.
  • 22
    Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002; 108: 1729.
  • 23
    Wu Z, Rosen ED, Brun R, et al. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 199;3: 151158.
  • 24
    De Crombrugghe B, Lefebre V, Behringer RR, et al. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000; 19: 389394.
  • 25
    Machwate M, Rodan SB, Rodan GA, et al. Sphingosine kinase mediates cyclic AMP suppression of apoptosis in rat periosteal cells. Mol Pharmacol. 1998; 54: 7077.
  • 26
    Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Rev. 2000; 21: 115137.